Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Surgery Partners Inc banner

Surgery Partners Inc
NASDAQ:SGRY

Watchlist Manager
Surgery Partners Inc Logo
Surgery Partners Inc
NASDAQ:SGRY
Watchlist
Price: 13.82 USD -1.64% Market Closed
Market Cap: $1.8B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

SGRY Price Targets Summary
Surgery Partners Inc

Wall Street analysts forecast SGRY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SGRY is 25.96 USD with a low forecast of 18.18 USD and a high forecast of 34.65 USD.

SGRY Lowest Forecast
Wall Street Target
18.18 USD
32% Upside
SGRY Average Forecast
Wall Street Target
25.96 USD
88% Upside
SGRY Highest Forecast
Wall Street Target
34.65 USD
151% Upside
Lowest
Price Target
18.18 USD
32% Upside
Average
Price Target
25.96 USD
88% Upside
Highest
Price Target
34.65 USD
151% Upside
Surgery Partners Inc Competitors:
Price Targets
JXN
Jackson Financial Inc
7% Upside
JXN
Jackson Financial Inc
7% Upside

Revenue
Forecast

23% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
23% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 12 years the compound annual growth rate for Surgery Partners Inc's revenue is 23%. The projected CAGR for the next 4 years is 7%.

What are analyst estimates?

Operating Income
Forecast

19% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
19% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 12 years the compound annual growth rate for Surgery Partners Inc's operating income is 19%. The projected CAGR for the next 3 years is 7%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

What are analyst estimates?

See Also

Summary
SGRY intrinsic value, competitors valuation, and company profile.
DCF Valuation
SGRY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SGRY stock valuation using valuation multiples.
Wall Street Estimates
SGRY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SGRY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SGRY's stock price target?
Price Target
25.96 USD

According to Wall Street analysts, the average 1-year price target for SGRY is 25.96 USD with a low forecast of 18.18 USD and a high forecast of 34.65 USD.

What is Surgery Partners Inc's Revenue forecast?
Projected CAGR
7%

For the last 12 years the compound annual growth rate for Surgery Partners Inc's revenue is 23%. The projected CAGR for the next 4 years is 7%.

What is Surgery Partners Inc's Operating Income forecast?
Projected CAGR
7%

For the last 12 years the compound annual growth rate for Surgery Partners Inc's operating income is 19%. The projected CAGR for the next 3 years is 7%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 315,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.